Belite Bio (BLTE) Return on Capital Employed (2023 - 2025)

Belite Bio's (BLTE) quarterly Return on Capital Employed came in at 2978301.27% in Q4 2025, down 296360610.0% year-on-year from N/an in Q4 2024, and up 59.48% quarter-over-quarter from 7350732.03% in Q3 2025.

Belite Bio (BLTE) Return on Capital Employed (2023 - 2025) Analysis & Trends

Belite Bio's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 2978301.27% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 296360610.0% year-over-year to 2978301.27% in Q4 2025; TTM through Dec 2025 was 2978301.27%, a 296360610.0% decrease from a year earlier, with the FY2025 full-year figure at 18.45%, up 1564.0% from the prior year.
  • Return on Capital Employed grew to 2978301.27% in Q4 2025 per BLTE's latest filing, from 7350732.03% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 14695.17% in Q4 2024 and bottomed at 7350732.03% in Q3 2025.
  • The 3-year median for Return on Capital Employed is 1498648.83% (2023), against an average of 2590681.22%.
  • Across the five-year window, Return on Capital Employed jumped 430122 bps in 2024 and plunged 296360610 bps in 2025, its largest moves.
  • Year by year, Return on Capital Employed stood at 18996.39% in 2023, then rose by 23 bps to 14695.17% in 2024, then slumped by 20167 bps to 2978301.27% in 2025.
  • Per Business Quant, the three latest BLTE Return on Capital Employed figures stand at 2978301.27% (Q4 2025), 7350732.03% (Q3 2025), and 14695.17% (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -31.80%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.46%
4 NuCana 279.75 Bn 279.75 Bn - -68.47%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 10.19%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -68.84%
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 20.34%

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,978,301.27%
Sep 30, 2025 -7,350,732.03%
Dec 31, 2024 -14,695.17%
Dec 31, 2023 -18,996.39%